1. Home
  2. INTT vs SKYE Comparison

INTT vs SKYE Comparison

Compare INTT & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$7.43

Market Cap

94.9M

Sector

Technology

ML Signal

HOLD

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$0.83

Market Cap

44.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTT
SKYE
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.9M
44.9M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
INTT
SKYE
Price
$7.43
$0.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$12.00
$14.75
AVG Volume (30 Days)
35.0K
350.9K
Earning Date
11-05-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$117,606,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.24
$0.82
52 Week High
$9.77
$5.75

Technical Indicators

Market Signals
Indicator
INTT
SKYE
Relative Strength Index (RSI) 46.17 28.16
Support Level $7.12 $0.82
Resistance Level $7.62 $0.95
Average True Range (ATR) 0.35 0.11
MACD -0.01 -0.01
Stochastic Oscillator 31.86 8.77

Price Performance

Historical Comparison
INTT
SKYE

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: